Mannkind (MNKD) Long-Term Investments (2021 - 2025)
Mannkind (MNKD) reported Long-Term Investments of $5.0 million for Q4 2025, down 8.57% year-over-year from $5.5 million in Q4 2024, and down 80.89% quarter-over-quarter from $26.2 million in Q3 2025.
Mannkind (MNKD) Long-Term Investments (2021 - 2025) Analysis & Trends
Mannkind (MNKD) has 5 years of Long-Term Investments data on file, last reported at $5.0 million in Q4 2025.
- Long-Term Investments for Q4 2025 came in at $5.0 million, down 8.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.0 million (down 8.57% YoY), and the FY2025 annual result was $5.0 million, down 8.57% from the prior year.
- Long-Term Investments retreated to $5.0 million in Q4 2025 per MNKD's latest filing, from $26.2 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $70.5 million in Q1 2022 and troughed at $492000.0 in Q1 2023.
- A 5-year average of $19.0 million and a median of $13.0 million in 2022 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2022 and 2023: Long-Term Investments surged 4600.0% in 2022, then tumbled 99.3% in 2023.
- A 5-year view of Long-Term Investments shows it stood at $56.6 million in 2021, then plunged by 96.54% to $2.0 million in 2022, then surged by 264.86% to $7.2 million in 2023, then fell by 23.38% to $5.5 million in 2024, then dropped by 8.57% to $5.0 million in 2025.
- Business Quant data shows MNKD's Long-Term Investments at $5.0 million in Q4 2025, $26.2 million in Q3 2025, and $22.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.01 Mn |
| Sep 30, 2025 | 26.23 Mn |
| Jun 30, 2025 | 22.24 Mn |
| Mar 31, 2025 | 16.68 Mn |
| Dec 31, 2024 | 5.48 Mn |
| Sep 30, 2024 | 16.80 Mn |
| Jun 30, 2024 | 13.40 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 7.16 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 492,000.00 |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 12.70 Mn |
| Jun 30, 2022 | 32.60 Mn |
| Mar 31, 2022 | 70.50 Mn |
| Dec 31, 2021 | 56.62 Mn |
| Sep 30, 2021 | 42.10 Mn |
| Jun 30, 2021 | 38.95 Mn |
| Mar 31, 2021 | 1.50 Mn |